Skip to content

Specialty Pharmacy Trends | Shields Care Model | Health System Operations | Cost of Care

The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care

This whitepaper explores how integrated health-system specialty pharmacy (HSSP) can transform CMD care—improving outcomes, reducing costs, and supporting patients through every stage of their journey.

By Shields Health Solutions
September 10th, 2025

Unlock Better Outcomes in Cardiometabolic Disease Care

Cardiometabolic disease (CMD) is one of the most pressing healthcare challenges of our time—driving trillions in costs and impacting millions of lives. From diabetes and cardiovascular disease to hypertension and metabolic liver conditions, CMD is complex, costly, and often treated in silos.

But what if there was a better way?

Download our white paper: The Role of Health System Specialty Pharmacy in Cardiometabolic Disease Care to explore how integrated health-system specialty pharmacy (HSSP) can transform CMD care—improving outcomes, reducing costs, and supporting patients through every stage of their journey.

Inside, you’ll discover:

  • The full spectrum of CMD—from early insulin resistance to advanced complications

  • The staggering financial and human toll of CMD-related conditions

  • Why siloed care models fall short—and how HSSP bridges the gap

  • Actionable insights for health systems, payers, and providers

Don’t miss this opportunity to rethink CMD care.
Empower your organization with strategies that make a real difference.